Experts have called for a balanced approach in medicine pricing that considers affordability, accessibility, and the growth of the pharmaceutical industry.
Experts have emphasized the need for transparent pricing mechanisms and increased state support within the pharmaceutical sector. According to them, medicine pricing policies must strike a careful balance between ensuring affordability for the public, maintaining accessibility, and fostering the overall growth of the industry.
